1. Home
  2. XPOF vs CGEN Comparison

XPOF vs CGEN Comparison

Compare XPOF & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$3.73

Market Cap

205.6M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.37

Market Cap

191.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPOF
CGEN
Founded
2017
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
191.1M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
XPOF
CGEN
Price
$3.73
$2.37
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
★ $8.13
$5.00
AVG Volume (30 Days)
★ 638.3K
184.2K
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 35.24
N/A
EPS
N/A
★ N/A
Revenue
★ $11,092,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.63
$75.09
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.57
$1.38
52 Week High
$9.25
$3.24

Technical Indicators

Market Signals
Indicator
XPOF
CGEN
Relative Strength Index (RSI) 32.43 41.25
Support Level N/A $2.34
Resistance Level $6.15 $2.54
Average True Range (ATR) 0.26 0.08
MACD -0.00 -0.02
Stochastic Oscillator 14.08 14.06

Price Performance

Historical Comparison
XPOF
CGEN

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: